Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,824,188
-$5,680,423 QoQ
Shares Held
266,062
0.0% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HSG Holding Ltd holds $37,256,055 across 5 Biotechnology names. GPCR ranks #2 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVBP |
ArriVent BioPharma, Inc.
|
663,308 | $15,302,515 | |
| 2 | GPCR |
Structure Therapeutics Inc.
This page
|
266,062 | $12,824,188 | |
| 3 | ADAG |
Adagene Inc.
|
1,343,364 | $5,265,986 | |
| 4 | LYEL |
Lyell Immunopharma, Inc.
|
152,299 | $3,055,117 | |
| 5 | BRNS |
Barinthus Biotherapeutics plc.
|
1,420,473 | $808,249 |
All Filings in GPCR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,824,188 | 266,062 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,504,611 | 266,062 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,449,736 | 266,062 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,518,125 | 266,062 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,605,532 | 266,062 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,215,601 | 266,062 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,677,460 | 266,062 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,448,254 | 266,062 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $45,645,128 | 1,064,982 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $43,418,611 | 1,065,226 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $53,708,694 | 1,065,226 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||